世界のβ-ラクタム系薬剤市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Beta-Lactam Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5615 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、β-ラクタム系薬剤の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ペニシリン、セファロスポリン、カルバペネム、モノバクテリア）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・β-ラクタム系薬剤の市場動向 ・企業の競争状況、市場シェア ・β-ラクタム系薬剤の種類別市場規模と予測2016-2027（ペニシリン、セファロスポリン、カルバペネム、モノバクテリア） ・β-ラクタム系薬剤の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局） ・β-ラクタム系薬剤の北米市場規模2016-2027（アメリカ、カナダ） ・β-ラクタム系薬剤の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・β-ラクタム系薬剤のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・β-ラクタム系薬剤の中南米市場規模2016-2027（メキシコ、ブラジル） ・β-ラクタム系薬剤の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GlaxoSmithKline plc、Pfizer, Inc.、AstraZeneca plc、Merck & Co., Inc.、Eli Lilly and Company、Shionogi & Co., Ltd.） ・結論

Market Analysis and Insights: Global Beta-Lactam Drugs Market
The global Beta-Lactam Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Beta-Lactam Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Beta-Lactam Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Beta-Lactam Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Beta-Lactam Drugs market.

Global Beta-Lactam Drugs Scope and Market Size
Beta-Lactam Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Beta-Lactam Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Penicillin
Cephalosporins
Carbapenem
Monobacteria

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline plc
Pfizer, Inc.
AstraZeneca plc
Merck & Co., Inc.
Eli Lilly and Company
Shionogi & Co., Ltd.

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Beta-Lactam Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Penicillin
1.2.3 Cephalosporins
1.2.4 Carbapenem
1.2.5 Monobacteria
1.3 Market by Application
1.3.1 Global Beta-Lactam Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Beta-Lactam Drugs Market Perspective (2016-2027)
2.2 Beta-Lactam Drugs Growth Trends by Regions
2.2.1 Beta-Lactam Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Beta-Lactam Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Beta-Lactam Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Beta-Lactam Drugs Industry Dynamic
2.3.1 Beta-Lactam Drugs Market Trends
2.3.2 Beta-Lactam Drugs Market Drivers
2.3.3 Beta-Lactam Drugs Market Challenges
2.3.4 Beta-Lactam Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Beta-Lactam Drugs Players by Revenue
3.1.1 Global Top Beta-Lactam Drugs Players by Revenue (2016-2021)
3.1.2 Global Beta-Lactam Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Beta-Lactam Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Beta-Lactam Drugs Revenue
3.4 Global Beta-Lactam Drugs Market Concentration Ratio
3.4.1 Global Beta-Lactam Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Beta-Lactam Drugs Revenue in 2020
3.5 Beta-Lactam Drugs Key Players Head office and Area Served
3.6 Key Players Beta-Lactam Drugs Product Solution and Service
3.7 Date of Enter into Beta-Lactam Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Beta-Lactam Drugs Breakdown Data by Type
4.1 Global Beta-Lactam Drugs Historic Market Size by Type (2016-2021)
4.2 Global Beta-Lactam Drugs Forecasted Market Size by Type (2022-2027)

5 Beta-Lactam Drugs Breakdown Data by Application
5.1 Global Beta-Lactam Drugs Historic Market Size by Application (2016-2021)
5.2 Global Beta-Lactam Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Beta-Lactam Drugs Market Size (2016-2027)
6.2 North America Beta-Lactam Drugs Market Size by Type
6.2.1 North America Beta-Lactam Drugs Market Size by Type (2016-2021)
6.2.2 North America Beta-Lactam Drugs Market Size by Type (2022-2027)
6.2.3 North America Beta-Lactam Drugs Market Size by Type (2016-2027)
6.3 North America Beta-Lactam Drugs Market Size by Application
6.3.1 North America Beta-Lactam Drugs Market Size by Application (2016-2021)
6.3.2 North America Beta-Lactam Drugs Market Size by Application (2022-2027)
6.3.3 North America Beta-Lactam Drugs Market Size by Application (2016-2027)
6.4 North America Beta-Lactam Drugs Market Size by Country
6.4.1 North America Beta-Lactam Drugs Market Size by Country (2016-2021)
6.4.2 North America Beta-Lactam Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Beta-Lactam Drugs Market Size (2016-2027)
7.2 Europe Beta-Lactam Drugs Market Size by Type
7.2.1 Europe Beta-Lactam Drugs Market Size by Type (2016-2021)
7.2.2 Europe Beta-Lactam Drugs Market Size by Type (2022-2027)
7.2.3 Europe Beta-Lactam Drugs Market Size by Type (2016-2027)
7.3 Europe Beta-Lactam Drugs Market Size by Application
7.3.1 Europe Beta-Lactam Drugs Market Size by Application (2016-2021)
7.3.2 Europe Beta-Lactam Drugs Market Size by Application (2022-2027)
7.3.3 Europe Beta-Lactam Drugs Market Size by Application (2016-2027)
7.4 Europe Beta-Lactam Drugs Market Size by Country
7.4.1 Europe Beta-Lactam Drugs Market Size by Country (2016-2021)
7.4.2 Europe Beta-Lactam Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Beta-Lactam Drugs Market Size (2016-2027)
8.2 Asia-Pacific Beta-Lactam Drugs Market Size by Type
8.2.1 Asia-Pacific Beta-Lactam Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Beta-Lactam Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Beta-Lactam Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Beta-Lactam Drugs Market Size by Application
8.3.1 Asia-Pacific Beta-Lactam Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Beta-Lactam Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Beta-Lactam Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Beta-Lactam Drugs Market Size by Region
8.4.1 Asia-Pacific Beta-Lactam Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Beta-Lactam Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Beta-Lactam Drugs Market Size (2016-2027)
9.2 Latin America Beta-Lactam Drugs Market Size by Type
9.2.1 Latin America Beta-Lactam Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Beta-Lactam Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Beta-Lactam Drugs Market Size by Type (2016-2027)
9.3 Latin America Beta-Lactam Drugs Market Size by Application
9.3.1 Latin America Beta-Lactam Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Beta-Lactam Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Beta-Lactam Drugs Market Size by Application (2016-2027)
9.4 Latin America Beta-Lactam Drugs Market Size by Country
9.4.1 Latin America Beta-Lactam Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Beta-Lactam Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Beta-Lactam Drugs Market Size (2016-2027)
10.2 Middle East & Africa Beta-Lactam Drugs Market Size by Type
10.2.1 Middle East & Africa Beta-Lactam Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Beta-Lactam Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Beta-Lactam Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Beta-Lactam Drugs Market Size by Application
10.3.1 Middle East & Africa Beta-Lactam Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Beta-Lactam Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Beta-Lactam Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Beta-Lactam Drugs Market Size by Country
10.4.1 Middle East & Africa Beta-Lactam Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Beta-Lactam Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline plc
11.1.1 GlaxoSmithKline plc Company Details
11.1.2 GlaxoSmithKline plc Business Overview
11.1.3 GlaxoSmithKline plc Beta-Lactam Drugs Introduction
11.1.4 GlaxoSmithKline plc Revenue in Beta-Lactam Drugs Business (2016-2021)
11.1.5 GlaxoSmithKline plc Recent Development
11.2 Pfizer, Inc.
11.2.1 Pfizer, Inc. Company Details
11.2.2 Pfizer, Inc. Business Overview
11.2.3 Pfizer, Inc. Beta-Lactam Drugs Introduction
11.2.4 Pfizer, Inc. Revenue in Beta-Lactam Drugs Business (2016-2021)
11.2.5 Pfizer, Inc. Recent Development
11.3 AstraZeneca plc
11.3.1 AstraZeneca plc Company Details
11.3.2 AstraZeneca plc Business Overview
11.3.3 AstraZeneca plc Beta-Lactam Drugs Introduction
11.3.4 AstraZeneca plc Revenue in Beta-Lactam Drugs Business (2016-2021)
11.3.5 AstraZeneca plc Recent Development
11.4 Merck & Co., Inc.
11.4.1 Merck & Co., Inc. Company Details
11.4.2 Merck & Co., Inc. Business Overview
11.4.3 Merck & Co., Inc. Beta-Lactam Drugs Introduction
11.4.4 Merck & Co., Inc. Revenue in Beta-Lactam Drugs Business (2016-2021)
11.4.5 Merck & Co., Inc. Recent Development
11.5 Eli Lilly and Company
11.5.1 Eli Lilly and Company Company Details
11.5.2 Eli Lilly and Company Business Overview
11.5.3 Eli Lilly and Company Beta-Lactam Drugs Introduction
11.5.4 Eli Lilly and Company Revenue in Beta-Lactam Drugs Business (2016-2021)
11.5.5 Eli Lilly and Company Recent Development
11.6 Shionogi & Co., Ltd.
11.6.1 Shionogi & Co., Ltd. Company Details
11.6.2 Shionogi & Co., Ltd. Business Overview
11.6.3 Shionogi & Co., Ltd. Beta-Lactam Drugs Introduction
11.6.4 Shionogi & Co., Ltd. Revenue in Beta-Lactam Drugs Business (2016-2021)
11.6.5 Shionogi & Co., Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Beta-Lactam Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Penicillin
Table 3. Key Players of Cephalosporins
Table 4. Key Players of Carbapenem
Table 5. Key Players of Monobacteria
Table 6. Global Beta-Lactam Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Beta-Lactam Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Beta-Lactam Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Beta-Lactam Drugs Market Share by Regions (2016-2021)
Table 10. Global Beta-Lactam Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Beta-Lactam Drugs Market Share by Regions (2022-2027)
Table 12. Beta-Lactam Drugs Market Trends
Table 13. Beta-Lactam Drugs Market Drivers
Table 14. Beta-Lactam Drugs Market Challenges
Table 15. Beta-Lactam Drugs Market Restraints
Table 16. Global Beta-Lactam Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Beta-Lactam Drugs Market Share by Players (2016-2021)
Table 18. Global Top Beta-Lactam Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Beta-Lactam Drugs as of 2020)
Table 19. Ranking of Global Top Beta-Lactam Drugs Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Beta-Lactam Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Beta-Lactam Drugs Product Solution and Service
Table 23. Date of Enter into Beta-Lactam Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Beta-Lactam Drugs Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Beta-Lactam Drugs Revenue Market Share by Type (2016-2021)
Table 27. Global Beta-Lactam Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Beta-Lactam Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Beta-Lactam Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Beta-Lactam Drugs Revenue Market Share by Application (2016-2021)
Table 31. Global Beta-Lactam Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Beta-Lactam Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Beta-Lactam Drugs Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Beta-Lactam Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Beta-Lactam Drugs Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Beta-Lactam Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Beta-Lactam Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Beta-Lactam Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Beta-Lactam Drugs Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Beta-Lactam Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Beta-Lactam Drugs Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Beta-Lactam Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Beta-Lactam Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Beta-Lactam Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Beta-Lactam Drugs Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Beta-Lactam Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Beta-Lactam Drugs Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Beta-Lactam Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Beta-Lactam Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Beta-Lactam Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Beta-Lactam Drugs Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Beta-Lactam Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Beta-Lactam Drugs Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Beta-Lactam Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Beta-Lactam Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Beta-Lactam Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Beta-Lactam Drugs Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Beta-Lactam Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Beta-Lactam Drugs Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Beta-Lactam Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Beta-Lactam Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Beta-Lactam Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 63. GlaxoSmithKline plc Company Details
Table 64. GlaxoSmithKline plc Business Overview
Table 65. GlaxoSmithKline plc Beta-Lactam Drugs Product
Table 66. GlaxoSmithKline plc Revenue in Beta-Lactam Drugs Business (2016-2021) & (US$ Million)
Table 67. GlaxoSmithKline plc Recent Development
Table 68. Pfizer, Inc. Company Details
Table 69. Pfizer, Inc. Business Overview
Table 70. Pfizer, Inc. Beta-Lactam Drugs Product
Table 71. Pfizer, Inc. Revenue in Beta-Lactam Drugs Business (2016-2021) & (US$ Million)
Table 72. Pfizer, Inc. Recent Development
Table 73. AstraZeneca plc Company Details
Table 74. AstraZeneca plc Business Overview
Table 75. AstraZeneca plc Beta-Lactam Drugs Product
Table 76. AstraZeneca plc Revenue in Beta-Lactam Drugs Business (2016-2021) & (US$ Million)
Table 77. AstraZeneca plc Recent Development
Table 78. Merck & Co., Inc. Company Details
Table 79. Merck & Co., Inc. Business Overview
Table 80. Merck & Co., Inc. Beta-Lactam Drugs Product
Table 81. Merck & Co., Inc. Revenue in Beta-Lactam Drugs Business (2016-2021) & (US$ Million)
Table 82. Merck & Co., Inc. Recent Development
Table 83. Eli Lilly and Company Company Details
Table 84. Eli Lilly and Company Business Overview
Table 85. Eli Lilly and Company Beta-Lactam Drugs Product
Table 86. Eli Lilly and Company Revenue in Beta-Lactam Drugs Business (2016-2021) & (US$ Million)
Table 87. Eli Lilly and Company Recent Development
Table 88. Shionogi & Co., Ltd. Company Details
Table 89. Shionogi & Co., Ltd. Business Overview
Table 90. Shionogi & Co., Ltd. Beta-Lactam Drugs Product
Table 91. Shionogi & Co., Ltd. Revenue in Beta-Lactam Drugs Business (2016-2021) & (US$ Million)
Table 92. Shionogi & Co., Ltd. Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Beta-Lactam Drugs Market Share by Type: 2020 VS 2027
Figure 2. Penicillin Features
Figure 3. Cephalosporins Features
Figure 4. Carbapenem Features
Figure 5. Monobacteria Features
Figure 6. Global Beta-Lactam Drugs Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Beta-Lactam Drugs Report Years Considered
Figure 11. Global Beta-Lactam Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Beta-Lactam Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Beta-Lactam Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Beta-Lactam Drugs Market Share by Regions (2022-2027)
Figure 15. Global Beta-Lactam Drugs Market Share by Players in 2020
Figure 16. Global Top Beta-Lactam Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Beta-Lactam Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Beta-Lactam Drugs Revenue in 2020
Figure 18. Global Beta-Lactam Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Beta-Lactam Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Beta-Lactam Drugs Market Share by Type (2016-2027)
Figure 22. North America Beta-Lactam Drugs Market Share by Application (2016-2027)
Figure 23. North America Beta-Lactam Drugs Market Share by Country (2016-2027)
Figure 24. United States Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Beta-Lactam Drugs Market Share by Type (2016-2027)
Figure 28. Europe Beta-Lactam Drugs Market Share by Application (2016-2027)
Figure 29. Europe Beta-Lactam Drugs Market Share by Country (2016-2027)
Figure 30. Germany Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Beta-Lactam Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Beta-Lactam Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Beta-Lactam Drugs Market Share by Region (2016-2027)
Figure 40. China Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Beta-Lactam Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Beta-Lactam Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Beta-Lactam Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Beta-Lactam Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Beta-Lactam Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Beta-Lactam Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Beta-Lactam Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. GlaxoSmithKline plc Revenue Growth Rate in Beta-Lactam Drugs Business (2016-2021)
Figure 60. Pfizer, Inc. Revenue Growth Rate in Beta-Lactam Drugs Business (2016-2021)
Figure 61. AstraZeneca plc Revenue Growth Rate in Beta-Lactam Drugs Business (2016-2021)
Figure 62. Merck & Co., Inc. Revenue Growth Rate in Beta-Lactam Drugs Business (2016-2021)
Figure 63. Eli Lilly and Company Revenue Growth Rate in Beta-Lactam Drugs Business (2016-2021)
Figure 64. Shionogi & Co., Ltd. Revenue Growth Rate in Beta-Lactam Drugs Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---